ASML and Anthropic: Technological and Political Challenges

A Colossal Machine at the Heart of Chip Innovation

Reaching the pinnacle of ASML's latest innovation is no small feat. This machine, comparable in size to a double-decker bus, weighs over 150 tons and represents a colossal investment of $400 million. For chip manufacturers looking to produce the most advanced components, this lithography equipment is essential.

In a world where artificial intelligence demands increasingly higher performance, ASML's machines play a crucial role. They use extreme ultraviolet (EUV) light to draw the tiny circuits of chips. This complex process involves firing lasers at small droplets of molten tin at an impressive rate of several tens of thousands of times per second.

ASML doesn't just manufacture these machines; it dominates the global market with about 90% share in the lithography tools sector. This dominant position raises concerns among some governments and market players, who see this hegemony as a potential risk. Competitors are emerging, seeking to carve out market share in this strategic field.

Anthropic and the Cybersecurity Dilemma

In April, Anthropic announced the development of an artificial intelligence model named Mythos, which it described as potentially risky for cybersecurity. To mitigate these risks, a more secure version, dubbed Fable, was launched. However, the U.S. government's reaction was swift: export controls were imposed on these models.

Faced with this pressure, Anthropic quickly decided to withdraw access to Mythos and Fable. This situation highlights the tensions between technological innovation and political regulation, with profound implications for the AI industry.

The warnings from "Doomers," who predict catastrophic scenarios related to AI, seem to have resonated in this case. Yet, this is a coding model, far removed from the apocalyptic scenarios often discussed. The authorities' response appears more like a political reaction than a well-considered security measure.

The Quest for Longevity: Science and Hopes

The biotechnology industry is buzzing, with billions of dollars invested in aging research. Scientists are exploring methods to reprogram cells and revert them to a younger state, promising spectacular advances in human longevity.

A virtual event organized by Roundtables and MIT Technology Review will delve into these developments. Mary Beth Griggs, science editor, and Jessica Hamzelou, senior biotechnology journalist, will host an exclusive discussion on Tuesday, June 30, reserved for subscribers.

Current News Points to Follow

1. Meta has suspended an AI training program following a leak of sensitive data.
2. Donald Trump signed an order supporting quantum computing, aiming for a scientific research system by 2028.
3. An AI lawyer won a lawsuit in England, marking a precedent in the legal field.
4. Tesla is under federal investigation after a fatal accident involving a Model 3.
5. Google DeepMind is collaborating with A24 to develop AI tools, with an investment of $75 million.
6. Nvidia is proposing a new data center design that reduces water usage through a closed-loop cooling system.
7. SpaceX is considering testing a spacecraft for cargo transport from orbit.
8. AI model trainers admit to using chatbots to accomplish their work.
9. A woman with Alzheimer's regained her speech after treatment with psilocybin.
10. Elon Musk and the NASA chief are exploring antimatter propulsion for interstellar travel.

A Notable Quote

"If AI is to help build a better future, it must be honest about what it costs us now." — António Guterres, UN Secretary-General, during London Climate Action Week, calls for transparency from AI companies regarding environmental costs.

Towards a Revolutionary Medical Future

Martine Rothblatt, a visionary entrepreneur, founded a biotechnology company after her daughter was diagnosed with a severe lung disease. Her ambition is to create an "unlimited supply of transplantable organs."

What once seemed unrealistic is gradually becoming a reality. Genetically modified pig organs have already been transplanted into humans, and United Therapeutics, Rothblatt's company, is working on 3D-printed lungs.

Rothblatt envisions a future where every organ in the human body could be 3D-printed, providing a pipeline of ready-to-use organs, thereby saving countless lives, including that of her daughter.

To End on a Light Note

Here are a few items to bring a little joy to your day:

• The original beer recipe of George Washington offers a tasty glimpse into American history.
• The song "Falling Away From Me" by Korn has been reinterpreted into a fusion jazz piece.
• Check out a gallery of 99 hilarious animal faces to brighten your morning.
• A 20-legged omnidirectional robot moves in all directions, reminiscent of a mechanical sea urchin.